Literature DB >> 20600799

In vitro evaluation of bis-pyridinium oximes bearing methoxy alkane linker as reactivators of sarin inhibited human acetylcholinesterase.

Jyotiranjan Acharya1, Devendra Kumar Dubey, Syed Kalbey Raza.   

Abstract

A series of bis-pyridinium oximes connected by methoxy alkane linkers were synthesized and their in vitro reactivation efficacy was evaluated against sarin-inhibited human AChE, and data were compared with 2-PAM and obidoxime. Among the synthesized compounds, 1,2-dimethoxy ethylene bis-[4,4'-(hydroxyiminomethyl) pyridinium] dichloride (4P-2) and 1,2-dimethoxy ethylene bis-[3,3'-(hydroxyiminomethyl) pyridinium] dichloride (3P-2) were found to be the most potent reactivators of human AChE inhibited by nerve agent sarin. The oximes 4P-2 and 3P-2 exhibited 41% and 36% regeneration of sarin-inhibited AChE, respectively, whereas 2-PAM showed 32% regeneration. The higher reactivation efficacy of the oximes was attributed to their acid dissociation constants (pK(a)). The pK(a) values of all the oximes were determined by UV-vis spectrophotometric method and correlated with their observed reactivation potential. Overall, the study reveals that the oxime 4P-2 may have therapeutic potential in the reactivation of human AChE inhibited by sarin. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20600799     DOI: 10.1016/j.tiv.2010.06.013

Source DB:  PubMed          Journal:  Toxicol In Vitro        ISSN: 0887-2333            Impact factor:   3.500


  2 in total

1.  Docking Studies, Synthesis, and In-vitro Evaluation of Novel Oximes Based on Nitrones as Reactivators of Inhibited Acetylcholinesterase.

Authors:  Seyed Ayoub Hosseini; Abolghasem Moghimi; Maryam Iman; Firoz Ebrahimi
Journal:  Iran J Pharm Res       Date:  2017       Impact factor: 1.696

2.  Broad-Spectrum Antidote Discovery by Untangling the Reactivation Mechanism of Nerve-Agent-Inhibited Acetylcholinesterase.

Authors:  Cecilia Lindgren; Nina Forsgren; Norman Hoster; Christine Akfur; Elisabet Artursson; Lotta Edvinsson; Richard Svensson; Franz Worek; Fredrik Ekström; Anna Linusson
Journal:  Chemistry       Date:  2022-06-07       Impact factor: 5.020

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.